Moderna Inc. buy UBS Group AG
Start price
26.06.23
/
50%
€111.22
Target price
26.06.24
€174.90
Performance (%)
2.48%
End price
27.06.24
€113.98
Summary
This prediction ended on 27.06.24 with a price of €113.98. The BUY prediction by UBS_Group_AG finished with a performance of 2.48%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Moderna Inc. | 6.859% | 6.859% | -73.644% |
iShares Core DAX® | 1.097% | 4.456% | 31.213% |
iShares Nasdaq 100 | -0.089% | 4.218% | 8.410% |
iShares Nikkei 225® | 5.046% | 5.461% | 2.669% |
iShares S&P 500 | 0.416% | 3.910% | 6.692% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $191.00 price target on the stock, down previously from $221.00.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten